Wiley Bros. Aintree Capital, LLC Elanco Animal Health Inc Transaction History
Wiley Bros. Aintree Capital, LLC
- $8.04 Billion
- Q4 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 10,498 shares of ELAN stock, worth $118,837. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,498Holding current value
$118,837% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ELAN
# of Institutions
437Shares Held
448MCall Options Held
1.16MPut Options Held
1.12M-
Dodge & Cox San Francisco, CA83.2MShares$942 Million0.63% of portfolio
-
Primecap Management CO Pasadena, CA51.2MShares$579 Million0.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.8MShares$552 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$264 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A620.4MShares$231 Million11.79% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.37B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...